# NiKang Therapeutics, Inc. — Form D

NiKang Therapeutics, Inc. of Wilmington, DE, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-07. The offering totals $200.0M, of which $200.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-06-07
- Form: D
- Accession: 0001567619-21-011735
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200.0M
- Amount sold: $200.0M
- Investors: 30
- Date of first sale: 2021-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401881

## Issuer

- Name: NiKang Therapeutics, Inc.
- CIK: 0001864608
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 200 Powder Mill Rd., Bldg E500, Wilmington, DE, 19803
- Phone: 302-644-5446

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Sean Cao | Director | Wilmington, DE |
| Wei Fu | Director | Grand Cayman, E9 |
| Zhenhai Gao | Director | Wilmington, DE |
| Ting Jia | Director | New York, NY |
| Roderick Wong | Director | New York, NY |
| Zhengbin Yao | Director | South San Francisco, CA |
| Gary Yeung | Director | Burlingame, CA |
| Hong (Kelsey) Chen | Executive Officer | Wilmington, DE |
| Zhenhai Gao | Executive Officer | Wilmington, DE |

## More

- [CIK 1864608 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1864608&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-21-011735.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.